BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25225283)

  • 1. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
    den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
    J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.
    de Rotte MC; den Boer E; de Jong PH; Pluijm SM; Ćalasan MB; Weel AE; Huisman AM; Gerards AH; van Schaeybroeck B; Wulffraat NM; Lindemans J; Hazes JM; de Jonge R
    Ann Rheum Dis; 2015 Feb; 74(2):408-14. PubMed ID: 24297383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Caldwell J; Kremer J
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
    Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
    Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
    Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
    Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
    Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
    de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
    Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
    Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
    Dervieux T; Greenstein N; Kremer J
    Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis.
    de Rotte MC; de Jong PH; den Boer E; Pluijm SM; Özcan B; Weel AE; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheumatol; 2014 Aug; 66(8):2026-36. PubMed ID: 24692301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
    Angelis-Stoforidis P; Vajda FJ; Christophidis N
    Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
    Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
    Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
    Dervieux T; Zablocki R; Kremer J
    Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children.
    Rahman SI; Siegfried E; Flanagan KH; Armbrecht ES
    J Am Acad Dermatol; 2014 Feb; 70(2):252-6. PubMed ID: 24332314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
    Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.